Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

2.170 -0.170 (-7.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
7 Unknown Biotech Stocks That Could Rocket in 2023 ↗
Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline. 
Via InvestorPlace
News headline image
Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes ↗
Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading. 
Via Benzinga
News headline image
SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside ↗
 
Via Benzinga
News headline image
Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments? ↗
Cell therapy — the use of stem cells and various engineered immune cells to target difficult-to-treat diseases like cancer and autoimmune conditions — has arguably been one of the big breakthroughs in... 
Via Benzinga
News headline image
Positive Clinical Results Put Nkarta Stock on the Fast Track ↗
NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program. 
Via InvestorPlace
News headline image
Expert Ratings for Nkarta ↗
Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: 
Via Benzinga
News headline image
Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022 ↗
  
Via Benzinga
News headline image
Executives Buy More Than $32M Of 3 Stocks ↗
Although US stocks closed sharply lower on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
How Is The Market Feeling About Nkarta Inc. - Common Stock? ↗
Nkarta Inc. - Common Stock's (NASDAQ:NKTX) short percent of float has risen 8.05% since its last report. The company recently reported that it has 1.84 million shares sold short,... 
Via Benzinga
News headline image
71 Biggest Movers From Yesterday ↗
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (... 
Via Benzinga
News headline image
34 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday... 
Via Benzinga
News headline image
Futures Slide Ahead Of Tech Earnings Deluge ↗
Markets in general are preoccupied by the prospect of tighter monetary policy conditions from global central banks to stem rising prices. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading. 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide ↗
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday. 
Via Benzinga
News headline image
34 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen... 
Via Benzinga
News headline image
Why Is Nkarta (NKTX) Stock Soaring 90% Today? ↗
Nkarta (NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical trial. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗
U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday. 
Via Benzinga
News headline image
Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More ↗
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items... 
Via Benzinga
News headline image
How Nkarta Stock Scored A 90% Surge On Its 'Natural Killers' In Cancer ↗
The biotech reported promising results for cell therapies without extreme side effects. 
Via Investor's Business Daily
News headline image
Why Nkarta Stock Is Soaring Today ↗
Nkarta Inc (NASDAQ: NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies. The... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
Via Benzinga
News headline image
43 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.